References
- Balding J, Healy CM, Livingstone WJ, et al. (2003). Genomic polymorphic profiles in an Irish population with meningococcaemia: Is it possible to predict severity and outcome of disease? Genes Immun, 4, 533–40.
- Bowcock AM, Kidd JR, Lathrop GM, et al. (1988). The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics, 3, 8–16.
- Coco AS. (1999). Primary dysmenorrhoea. Am Fam Physician, 60, 489–96.
- Cussigh A, Falleti E, Fabris C, et al. (2011). Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics, 63(1), 33–41.
- Davis AR, Westhoff CL. (2001). Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol, 14(1), 3−8.
- Dawood MY. (2006). Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol, 108(2), 428–41.
- Fishman D, Faulds G, Jeffery R, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest, 102, 1369–76.
- French L. (2005). Dysmenorrhea. Am Fam Physician, 71(2), 285−91.
- Henriet P, Chevronnay HPG, Marbaix E. (2012). The endocrine and paracrine control of menstruation. Mol Cell Endocrinol, 358, 197–207.
- Hsieh YY, Wang YK, Chang CC, Lin CS. (2006). Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod, 13(2), 117–22.
- Hulkkonen J, Pertovaara M, Antonen J, et al. (2001). Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford), 40, 656–61.
- Ioannidis JP, Ralston SH, Bennett ST, et al. (2004). Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA, 292, 2105–14.
- Karakus N, Yigit S, Rustemoglu A, et al. (2014). Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis. Arch Dermatol Res, 306(2), 173–80.
- Lee CH, Roh J-W, Lim C-Y, et al. (2011). A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of a far infrared-emitting sericite belt in patients with primary dysmenorrhea. Complement Ther Med, 19, 187–93.
- Ma H, Hong M, Duan J, et al. (2013). Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: A case-control study. PLoS One, 8(2), e55200.
- Ma YX, Ma LX, Liu XL, et al. (2010). A comparative study on the immediate effects of electroacupuncture at Sanyinjiao (SP6), Xuanzhong(GB39) and a non-meridian point, on menstrual pain and uterine arterial bloodflow, in primary dysmenorrhea patients. Pain Med, 11, 1564–75.
- Menasce LP, White GRM, Harrison CJ, Boyle JM. (1993). Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics, 17, 263–5.
- Molvarec A, Vér A, Fekete A, et al. (2007). Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res, 30(3), 205–11.
- Morse HR, Olomolaiye OO, Wood NA, et al. (1999). Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine, 11, 789–95.
- Neighbors LE, Clelland J, Jackson JR, et al. (1987). Transcutaneous electrical nerve stimulation for pain relief in primary dysmenorrhea. Clin J Pain, 3, 17–22.
- Ponglikitmongkol M, Green S, Chambon P. (1988). Genomic organization of the human oestrogen receptor gene. EMBO J, 7, 3385–8.
- Ribas V, Nguyen MT, Henstridge DC, et al. (2010). Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol, Endocrinol Metab, 298(2), E304–E319.
- Schuit SC, de Jong FH, Stolk L, et al. (2005). Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol, 153, 327–34.
- Schuit SC, van Meurs JB, Bergink AP, et al. (2004). Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J Clin Endocrinol Metab, 89, 303–9.
- Stavrou I, Zois C, Chatzikyriakidou A, et al. (2006). Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche. Hum Reprod, 21(2), 554–7.
- Tan D, Wu X, Hou M, et al. (2005). Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol, 174, 753–6.
- Valentin L, Sladkevicius P, Kindahl H, et al. (2000). Effects of a vasopressin antagonist in women with dysmenorrhea. Gynecol Obst Invest, 50(3), 170−7.
- van Duijnhoven FJ, Bezemer ID, Peeters PH, et al. (2005). Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev, 14, 2655–60.
- Weel AE, Uitterlinden AG, Westendorp IC, et al. (1999). Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab, 84(9), 3146–50.
- Woo HY, Kim KH, Lim SW. (2010). Estrogen receptor 1, glutathione S-transferase P1, glutathione S-transferase M1, and glutathione S-transferase T1 genes with dysmenorrhea in Korean female adolescents. Korean J Lab Med, 30(1), 76–83.
- Yeh ML, Chen HH, So EC, Liu CF. (2004). A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan. Life Sciences, 75, 669–73.
- Zofkova I, Zajickova K, Hill M. (2002). The estrogen receptor alpha gene determines serum androstenedione levels in postmenopausal women. Steroids, 67, 815–19.